Member Info for itsallamess

Https://www.inderes.fi/analyst-comments/faronin-esmo-tiedote-taydensi-aiemmin-kerrottuja-paatuloksia

https://www.linkedin.com/posts/faron_wodc-wodceu2025-faronpharmaceuticals-activity-7386295318717399041-5iEK?utm_source=share&utm_medium=member_android&rcm=ACoAAAGqaz4BXKfrVRvYM3TqkStqcjyeyLusq1g

We are excited to announce that Ralph Hughes, CBO at Faron Pharmaceuticals, will be attending the World Orphan Drug Congress (WODC) in Amsterdam.

💬 Ralph is taking part in a panel discussion focused on the unique challenges of the European orphan drug market and the importance of early, evidence-based planning in the pre-congress workshop day on 27 October, at 15:00–16:00 CET. The panel will also feature Andrew Cummins (Vice President, Business Development, Sciensus) and Doug Niven (European Strategic Consultant, Sciensus). 💬

Topics to be discussed include:

- Designing for EU HTA/JCA: the evidence you need by Phase 2

- Pricing architecture & launch sequencing: protecting value across Europe

- Patient-centred access: integrating real-world data, support programs and partnerships

- Build, partner or outsource? Smart commercial pathways

The World Orphan Drug Congress is the largest and most established orphan drug & rare disease meeting of its kind across the globe and is held on 28–29 October 2025 in Amsterdam.

#WODC #WODCEU2025 #faronpharmaceuticals

Https://www.linkedin.com/posts/faron_wodc-wodceu2025-faronpharmaceuticals-activity-7386295318717399041-5iEK?utm_source=share&utm_medium=member_android&rcm=ACoAAAGqaz4BXKfrVRvYM3TqkStqcjyeyLusq1g

We are excited to announce that Ralph Hughes, CBO at Faron Pharmaceuticals, will be attending the World Orphan Drug Congress (WODC) in Amsterdam.

💬 Ralph is taking part in a panel discussion focused on the unique challenges of the European orphan drug market and the importance of early, evidence-based planning in the pre-congress workshop day on 27 October, at 15:00–16:00 CET. The panel will also feature Andrew Cummins (Vice President, Business Development, Sciensus) and Doug Niven (European Strategic Consultant, Sciensus). 💬

Topics to be discussed include:

- Designing for EU HTA/JCA: the evidence you need by Phase 2

- Pricing architecture & launch sequencing: protecting value across Europe

- Patient-centred access: integrating real-world data, support programs and partnerships

- Build, partner or outsource? Smart commercial pathways

The World Orphan Drug Congress is the largest and most established orphan drug & rare disease meeting of its kind across the globe and is held on 28–29 October 2025 in Amsterdam.

#WODC #WODCEU2025 #faronpharmaceuticals

BmHltd is back spamming the board with his chatGPT..

Whats the point using AI.. totally kills human discussion on here which is the point of this message board..

If a partner isnt on board, after all the talk of one needed, they will have to give some good explanation why.. In detail.. especially if they come cap in hand to investors.

Although they did proclaim that the last public raise was the last ever.. so not sure we will get a look in on any placing if one goes ahead

No worried about Lind selling up, he never maintained his percentage shares over the years.. he probably has other stocks that interest him. He was here a long time, everyone moves on to something else over time.

But it would appear that his shares have a new home somewhere so no big deal

08-Oct-25 16:30:52 179.50 63,000 Unknown* 113.09k

Popped up today, a trade pushed through at the end of day yesteday.. from the price, it has to be a buy..

Is some manipulationgoing on letting someone in on the cheap? Someone who has got a very large order to fill thats taking a long time?

I can the SP shooting up soon.. unless we get dilution news.. could really go 50/50

Juhu seems very quite, its either cause he gonna let us all down, or he is gaged from speaking cause a deal is in full negotiation phase!

We all hope the later im sure!

All the big trades.. buys or sells?

One of these Monday mornings we will wake up to a RNS with life changing share price news.. will it be this Monday?

Is that 290k of buys or sells today?

Theres always a drift down when there isnt anything news.. and they are placing is done!

We are at a pivotal moment with Faron.. a partner deal or hobble along with another fund raise for a few months..

Its hard to know which way this is gonna go..

Https://www.birminghambrc.nihr.ac.uk/news-and-events/new-data-sheds-light-on-immunotherapy-failure-bringing-hope-to-patients-with-cancer

This is good, they have rights to buy more shares under this 2015 deal.. time is running out to g see t them.. they now own more share in faton.

Yes they are cheap.. thats the price set from back then.. good for them, and a good sign the top people believe in the company!

Https://www.linkedin.com/safety/go?url=https%3A%2F%2Flnkd.in%2FedFvMTJ4%3Ftrk%3Dfeed-detail_main-feed-card-text

Page 5

Are they looking at doing phase 3 themselves...?

CUtting and pasting your comments from one of the AI models like you are isnt that smart either.

Enjoy your ego trip

Bmh, your reply just proves my point!

Bmh, you appear to be know alot.

Ive been on this board since around 2018. I enjoy reading other people's posts. Some are accurate, some not..

Everyone is entitled to their view.

Here's my view.

Breaking down someone's post and commenting on every sentence like you just did, makes you look like a d i c k. 😂

With the information that we know about phase 3, if faron were to fund this themselves, how much are we looking at that they would need to raise?

But its for 19 shares! Thats big 😂

Https://faron.events.inderes.com/q2-2025/register

A virtual briefing and Q&A session for investors, analysts and media will be hosted by Dr. Juho Jalkanen, Chief Executive Officer, Yrjö Wichmann, Chief Financial Officer and Dr. Petri Bono, Chief Medical Officer, at 09:00 am (EDT) / 2:00 pm (BST) / 4:00 pm (EEST) on Wednesday, 27 August 2025. Webcast registration link: Faron 2025 Half-Year Financial Results